Trastuzumab-Botidotin: Advancing HER2-targeted therapy into a new...

bir ses eklendi Health

2026-01-07 09:02:03

Trastuzumab-Botidotin: Advancing HER2-targeted therapy into a new era of dual-epitope synergistic effects

As precision oncology continues to evolve, HER2 (human epidermal growth factor receptor 2) has become one of the most established and clinically valuable therapeutic targets across a wide range of solid tumors. With growing insight into tumor heterogeneity and resistance mechanisms, the limitations of single-target, single-mechanism therapies are increasingly apparent. Improving efficacy while...

0 Yorumlar 0 hisse senetleri 533 Views 0 önizleme